“Curcumins and its derivatives as potential inhibitors of New Coronavirus (COVID-19) main protease: an in silico strategy”, RSD, vol. 11, no. 1, p. e6511124334, Jan. 2022, doi: 10.33448/rsd-v11i1.24334.